Skip to main content
Experimental and Therapeutic Medicine logoLink to Experimental and Therapeutic Medicine
. 2017 Jul 11;14(3):2007–2014. doi: 10.3892/etm.2017.4780

Nearly asymptomatic intracranial capillary hemangiomas: A case report and literature review

Xiaoyu Xia 1, Haoju Zhang 1, Hongyan Gao 2, Yi Yang 1, Yiwu Dai 1, Yang Jiao 3, Jianghong He 1,
PMCID: PMC5609166  PMID: 28962117

Abstract

The present study reported a nearly asymptomatic case of intracranial capillary hemangioma (ICHs), which are rare benign vascular tumors or tumor-like lesions. A 33-year-old female came to the hospital with a complaint of a slight but recurring morning headache concentrated in the left posterior occipital area. These headaches spontaneously resolved without any treatment. Computed tomography and magnetic resonance imaging revealed a mass inside the left occipital lobe. The patient refused to undergo conservative observation at home and insisted on radical therapy. Prior to surgery, an atypical meningioma or astrocytoma was suspected. A navigation-guided brain-mass resection was performed under general anesthesia and a solid mass closely associated with the tentorium cerebelli was completely resected. Histopathological analysis confirmed diagnosis of an ICH. The patient recovered well and experienced no major neurological defects, apart from an issue with the right visual field. The present study also conducted a retrospective literature review of papers published in English describing cases of intracranial capillary hemangiomas. A PubMed search identified 19 articles comprising 29 cases. The clinical symptoms of ICH are diverse and all reported cases in the literature were symptomatic. Previous studies demonstrated that diagnoses of intracranial capillary hemangioma are usually made during surgical resection by histopathological examination. Treatment for ICH remains empirical and surgery is the most common method of treatment. Patient prognosis is generally good-the majority of patients achieve long-term, event- and progression-free survival.

Keywords: intracranial capillary hemangioma, intracranial, diagnosis, asymptomatic, literature review

Introduction

Capillary hemangiomas (CHs) are benign vascular tumors or tumor-like lesions that usually occur at birth or in early infancy. Typically, the lesions involve skin and soft tissue, and are usually found on the face, scalp, chest, or back (1,2). They have been reported to occur in 1.1 to 2.6% of full-term neonates, with an estimated frequency of 10 to 12% within the first year of life (2). They are characterized by a proliferative phase followed by an involutionary phase and patients often experience spontaneous regression with age (2,3). Lesions can occur in adults, occur more often in women than men and undergo changes in size relative to hormonal cycles and pregnancy (2).

CHs involving the nervous system are rare (4) and primarily occur in the spinal nerve roots or cauda equina (5,6). Intracranial capillary hemangiomas (ICHs) are even rarer; only 29 cases have been reported so far, however the intracranial location of these lesions varies. All reported cases were confirmed histologically however no patients were diagnosed prior to pathological examination. Clinical experience of this disease is poor and the lesion is usually considered to be a meningioma prior to surgery (7). Due to the small number of reported cases, the true prevalence of ICHs may be underestimated as they may remain asymptomatic or undergo spontaneous regression (3).

The current study reported a case of ICH in a patient admitted to the Department of Neurosurgery, PLA Army General Hospital (Beijing, China). Furthermore, previous studies investigating the diagnosis, differential diagnosis with other brain tumors such as meningiomas, and treatment for ICHs were reviewed.

Case report

A 33-year-old woman attended the Department of Neurosurgery, PLA Army General Hospital in December 2014 with the complaint of a minor morning headache for 7 days that was concentrated in the left posterior occipital area. The headache was alleviated following rest. The patient had suffered from mild hypertension for nearly 5 years since her last pregnancy but her blood pressure was well controlled with oral medication of amlodipine benzenesulfonate (Pfizer, Inc., New York, NY, USA; 10 mg a day). The patient was examined at the outpatient clinic of the Department of Neurosurgery, PLA Army General Hospital and underwent computed tomography (CT) and magnetic resonance imaging (MRI) scans, which revealed a mass inside the left occipital lobe (Figs. 1 and 2). The patient refused conservative observation at home and insisted on undergoing radical therapy, and was subsequently admitted to the Department of Neurosurgery, PLA Army General Hospital on March 9th, 2015. Although no medical treatment was given to the patient prior to surgery, the patient experienced no further headaches and no fever, nausea or vomiting. Following admittance to hospital, examinations identified no signs of neurological damage. All the aspects of the present study complied with the Declaration of Helsinki, 1995. Written informed consent was obtained from the patient and family members and the present study was authorized by the Ethics Committee of the Department of Neurosurgery, PLA Army General Hospital (Beijing, China).

Figure 1.

Figure 1.

Computed tomography of the patient's brain prior to surgery. A high-density, round mass (indicated by the arrow was detected with a diameter of ~2.0 cm and areas of higher density inside the left occipital lobe. Edema was observed along the edges.

Figure 2.

Figure 2.

Brain magnetic resonance imaging of the current patient prior to surgery. A mass with heterogeneous, long T1 and T2 signals located inside the left occipital lobe and was near the posterior horn of the left ventricle close to the tentorium. Marked uneven reinforcement was observed when enhanced.

Atypical meningioma or astrocytoma was suspected. A routine cerebral angiography was performed through the right femoral artery puncture with an Artis Zeego angiographic system (Siemens AG, Munich, Germany). Iodixanol injection was used as the contrast agent. This revealed a hypervascular lesion that was primarily supplied by the meningohypophyseal trunk; however, no evident draining vein was identified (Fig. 3). A navigation-guided brain-mass resection was performed under general anesthesia. Sufentanil (IDT Biologika GmbH, Dessau-Rosslau, Germany; 25 µg), propofol (AstraZeneca, Cambridge, UK; 100 mg) and rocuronium bromide (N.V. Organon; Merck KGaA, Darmstadt, Germany; 50 mg) were used to induce anesthesia. Propofol (AstraZeneca, 200 mg/h) and remifentanil (Yichang Humanwell Pharmaceutical Co., Ltd., Yichang, China; 1,000 µg/h) were used to maintain anesthesia. High intracranial pressure was detected during surgery. At first, entry was attempted through the tentorium cerebelli space to reduce brain damage but this failed. Eventually the occipital cortex was perforated to get to the tumor directly.

Figure 3.

Figure 3.

Cerebral vascular angiography of the current patient prior to surgery. Abnormal architecture of tumor vascularity was detected, including chaotic distribution, tumor staining and pooling of contrast material. Clear time of contrast agent at tumor area was ~5 sec later than other areas. The arrow indicates tumor location.

A solid mass closely associated with the tentorium cerebelli was completely resected. Intraoperative bleeding was kept under control and no substantial bleeding was encountered; however, an infratentorial epidural hematoma formed following surgery. This was identified 24 h after surgery in the routine CT exam, requiring a second operation of hematoma evacuation (Fig. 4). The patient recovered well with no major neurological defects apart from a half visual field defect (right temporal side). An MRI scan performed ~2 months later revealed no recurrence of the tumor (Fig. 5); however, the right visual field defect persisted and the patient is being observed in the outpatient clinic every 3 months.

Figure 4.

Figure 4.

Computed tomography of the patient 1 day after initial surgery indicating complete resection of the tumor. An infratentorial epidural hematoma was detected near the surgery area (indicated by arrow).

Figure 5.

Figure 5.

Post-gadolinium axial T1-weighted image from the scan performed on the patient ~2 months following initial surgery. No recurrence of the tumor was detected and the surgical pathway through the cortex is clearly presented.

Histopathological analysis

Histopathological analysis confirmed diagnosis of ICH. On visual inspection, the completely resected tumor was similar to a dark-red mulberry with multiple prominences. It was a firm, solid, 2.2- × 1.6- × 1.7-cm mass with a broad-based dural attachment (Fig. 6A). Sectioning identified a dark-grey, oozing cut surface.

Figure 6.

Figure 6.

Histopathological observations of the tumor itself. (A) The tumor was completely resected as a dark-red, firm, solid, 2.2×1.6×1.7 cm mass with a broad-based dural attachment. (B) Photomicrographs of the surgical specimen identified the area encompassed by the tumor with moderate-to-dense cellularity containing numerous vascular channels and spaces. Hematoxylin and eosin staining, magnification ×100. (C and D) Vascular structures and the endothelial cell lining of this tumor exhibited high expression of the vascular markers CD31 and CD34. CD31 and CD34 immunohistochemical staining, magnification ×100.

The tumor tissue was fixed with 10% neutral buffered formalin at room temperature for 72 h. Sections (4 µm) were stained with hematoxylin and eosin and examined under a light microscope (Olympus BX53; Olympus Corporation, Tokyo, Japan). Microscopic examination revealed a vascular malformation with thin-walled and delicate vessels, which varied greatly in size from a small lumina lined with plump endothelial cells to dilated vessels lined with flattened endothelium; red blood cells were observed within the vessel lumens (Fig. 6B). No intervening brain tissues or hemosiderin deposits were identified. There was no evidence of nuclear atypia, significant mitotic activity or cytoplasmic hyaline globules and no morphological evidence of metastasis.

Immunohistochemistry

Immunohistochemical staining was performed using the EnVision system (Agilent Technologies, Inc.). Briefly, serial 5-µm-thick sections were cut from formalin-fixed and paraffin-embedded tumor blocks, dewaxed in xylene, rehydrated through sequential changes of alcohol, and then antigen retrieved using 0.01 M citrate buffer, pH 6.0, at 90°C for 20 min. After the tissue sections were washed with PBS, they were incubated with fresh 3% hydrogen peroxide for 20 min at room temperature. The sections were then blocked with 20% goat serum for 30 min and incubated with the following primary antibodies for 2 h at room temperature: Anti-EMA (ab156947; 1:150 dilution; Abcam, Cambridge, UK), anti-progesterone receptor (ab32085; 1:100 dilution; Abcam), anti-S100 (ab14849; 1:3,000 dilution; Abcam), anti-SOX2 (ab92494; 1:100 dilution; Abcam), anti-GFAP (ab7260; 1:1,000 dilution; Abcam), anti-NeuN (ab177487; 1:3000 dilution; Abcam) anti-Olig2 (ab109186; 1:100 dilution; Abcam), anti-CD31 (ab28364; 1:50 dilution; Abcam), anti-CD34 (ab81289; 1:2500 dilution; Abcam) and anti-vimentin (ab28028; 1:100 dilution; Abcam). The sections were then incubated with a secondary antibody Envision FLEX+ (K8002; Agilent Technologies, Inc.) for 20 min at room temperature. Immunostaining was finally developed with 3,3-diaminobenzidine. Positive and negative controls were run as appropriate. The sections were assessed independently by two experienced pathologists. Immunostaining with epithelial membrane antigen, progesterone receptor, S-100, sex determining region Y-box 2, glial fibrillary acidic protein, neuronal nuclei and Oligo-2 (all Abcam) exhibited negative results, while immunostaining with cluster of differentiation 31 (CD 31), CD 34 and vimentin (all Abcam exhibited strong positive results, which implied vascular proliferation (Fig. 6C and D). The vascular nature of the lesion was confirmed and a diagnosis of meningioma was ruled out.

Discussion

CHs are relatively common benign vascular tumors that occur in 1.0–2.6% of live births and are generally located in the skin and soft tissues (8). These tumors are more common in females than males and may undergo changes in size according to hormonal fluctuations and pregnancy (2). CHs involving the central nervous system are rare. The majority of documented cases have been identified in the spinal roots and the cauda equina. ICHs are even more rare. In the current study, a search was conducted using the query ‘intracranial and capillary hemangioma’ on Pubmed (https://www.ncbi.nlm.nih.gov/pubmed/) and 19 articles were identified reporting 29 cases of ICH that were histologically confirmed (Table I).

Table I.

Previous cases of intracranial capillary hemangiomas.

Case no. Author, year Patient age, sex Intracranial tumor location Symptoms Surgery Other treatment for ICH ICH recurrence Other tumors Result Relationship to pregnancy (Refs.)
  1 Willing et al, 1993 17 months, male Right temporal lobe, dural based Seizures Total resection No No NR NR (9)
  2 Tsao et al, 2003 15 years, female Right cavernous sinus Right-sided VI, III cranial nerve palsy Biopsy sampling and partial removal Stereotactic fractionated radiation therapy No NR Nearly complete resolution of tumor, persistent cranial nerve palsy (15)
  3 Tsao et al, 2003 19 years, female Left cavernous sinus Left-sided VI cranial nerve palsy Biopsy sampling Stereotactic fractionated radiation therapy No NR Nearly complete resolution of tumor, persistent cranial nerve palsy (15)
  4 Abe et al, 2004 20 years, male Multiple, frontoparietal lobes Headache, seizures Partial resection Systemic administration of corticosteroid drugs followed by IFNα No NR RW (4)
  5 Abe et al, 2004 16 years, female Multiple, cerebrum and cerebellum Diplopia Partial resection Systemic administration of corticosteroid drugs followed by IFNα No NR RW (4)
  6 Abe et al, 2004 8 years, male Left temporal lobe Headache, nausea Total resection No No NR RW (4)
  7 Simon et al, 2005 31 years, female Left occipital lobe and left cerebellar, hemisphere tentorium based Severe headaches, nausea and vomiting 3 times (partial resection 2 times, gross total resection last time) No Yes NR twice RW During pregnancy (2)
  8 Le Bihannic et al, 2005 6 weeks, male Anterior choroidal artery Vomiting and disturbance of consciousness, left hemiparesis No No Hemangiomas found on the eyelid and thigh Succumbed (17)
  9 Brotchi et al, 2005 10 years, female Lumen of the superior sagittal sinus Intracranial hypertension Partial resection No No NR RW (16)
10 Karikari et al, 2006 3 months, male Fourth ventricle Central hypotonia Total resection No No NR RW (8)
11 Smith 26 years, Left petrous temporal region Severe frontal headaches associated with one episode of vomiting Total resection No No NR RW During pregnancy (21)
12 Uyama et al, 2008 4 months, female Left cerebellar hemisphere Hydrocephalus Total resection Corticosteroids No Hemangiomas distributed widely throughout body. NR (3)
13 Daenekindt et al, 2008 7 weeks, male Right temporal fossa Head enlargement Total resection No No Not found RW (1)
14 Maurer et al, 2010 44 years, female Multiple, left temporal lobe POEMS syndrome Resection 3 times No No Not found NR (19)
15 Lee et al, 2010 59 years, female Pituitary stalk and infundibular recess Severe headache Endoscopic biopsy NR NR NR NR (23)
16 Younas et al, 2011 69 years, male Multiple, subcortical regions in bilateral hemispheres Transient cerebrovascular insufficiency Biopsy sampling No NR Not found NR (20)
17 Phi et al, 2012 8 years, male Right occipital lobe involving the right tentorium and transverse sinus Intracranial hypertension and decreased Nearly total resection No No NR RW (7)
18 Phi et al, 2012 13 years, male Right temporo-occipital area Worsening headache Partial resection Required, but no details Yes NR Under close observation for potential further treatment (7)
19 Phi et al, 2012 30 years, female Posterior fossa, attached to the tentorium Worsening headache, vomiting, and vertigo Total resection No No NR RW (7)
20 Phi et al, 2012 44 years, female Ethmoid and sphenoid sinuses Progressive visual loss and field cut in the right eye Partial resection Radiation therapy (5,400 cGy to the mass) No NR RW (7)
21 Morace 26 years, female Sellar lesion extending into the right cavernous sinus and anterior temporal region Galactorrhea and irregular menstrual cycles as well as high serum prolactin levels Partial resection Radiotherapy No NR RW (18)
22 Morace et al, 2012 61 years, female Sellar lesion extending into the left cavernous sinus Left eye visual impairment and a left second trigeminal branch sensory deficit Partial resection Stereotactic radiotherapy with Cyberknife No NR RW (18)
23 Morace et al, 2012 14 years, male Left middle cranial fossa, extending into the cerebello-pontine angle and infratemporal fossa Left VII cranial nerve palsy, left deafness, dysphagia, and vertigo Partial resection Radiotherapy after recurrence Yes NR RW (18)
24 Morace et al, 2012 42 years, male Left temporoparietal area Dysphasia Total resection No No NR RW (18)
25 John et al, 2012 59 years, male Right temporoparietal region Transient focal neurological deficits and behavioral abnormalities mimicking Ganser's syndrome Total resection No No NR RW (24)
26 Zheng et al, 2012 3 years, male Right middle cranial fossa Progressively enlarged subcutaneous, mass somnolence, vomiting and ptosis of the right eyelid Total resection No No NR RW (25)
27 Mirza et al, 2013 28 years, female Right temporal region adjacent to the transverse sinus Occipital Seizures Total resection No No NR RW Symptoms started during pregnancy (22)
28 Mirza et al, 2013 41 years, female Occipital region Progressive visual disturbance Total resection No No NR RW Symptoms started during pregnancy (22)
29 Jalloh et al, 2014 2 weeks, male Left middle fossa Intracranial hypertension Biopsy followed by total resection No No NR RW (10)

NR, not reported; IFN, interferon; RW, recovered well.

The 29 cases included 14 male and 15 female patients with ICH ranging in age from 2 weeks to 69 years. The avaliable data were limited, however there were no significant differences in cases based on sex. Data regarding age demonstrated that the majority of patients were infants (7) and young adults <30 years old. Furthermore, only one case of ICH was reported prior to 2000 (9). One possible reason for this is that similar cases may have been described using other terms of pathological diagnosis (4). Due to greater in-depth knowledge of ICH gleaned from pathology reports, an increasing number of cases have been identified more recently. However, accurately diagnosing all cases of ICH is nearly impossible due to the use of non-standardized nomenclature to describe intracranial vascular lesions. One case with mixed capillary and cavernous hemangioma histology was included in the current study (10), however other similar cases may not have been correctly diagnosed and therefore were not correctly reported. Four cases of intraosseous CH were not included (1114).

Despite the fact that ICH exhibits consistant pathological features, the clinical characteristics of the disease exhibit a high degree of heterogeneity. ICH can grow in the cerebral lobe (4,9), cavernous sinus (15), lumen of the superior sagittal sinus (16), cerebellum (4), anterior choroidal artery (17), fourth venticle (8) and sellar region (18). Following analysis of the 29 cases, no predilection for a specific site of ICH growth was apparent and in a number of cases, only a single lesion was detected but there were multiple tumors (4 of 29 reported cases) (4,19,20). The clinical symptoms of ICH are very diverse and differ according to tumor location and size. All reported cases in the literature were symptomatic and more common symptoms include headaches, cranial nerve palsy and/or seizures. In 4 of the previously reported cases, ICH was associated with pregnancy (2,21,22). By contrast, the patient in the current study was nearly asymptomatic and visited the hospital due to a slight but recurring morning headache that increased in intensity. However, these headaches spontaneously resolved without any treatment; therefore, the patient experienced no marked symptoms associated with ICH, aside from anxiety, prior to initial surgery. An intracranial lesion was detected by neuroimaging examination, however it could not be confirmed that the headaches were associated with the lesion.

The patient had last been pregannt 5 years ago, which resulted in mild hypertension and the patient's blood pressure was controlled by oral medication. The tumor may have been associated with this pregnancy and may have therefore been present for several years. The tumor that was resected during surgery was solid and small and may have been in an involution phase by the time it was detected. All these factors further support the hypothesis that the incidence of ICH may be underreported, particularly if the tumor regresses in size over time and remains asymptomatic.

Mutiple differential diagnoses were noted in previous studies but there was limited information avaliable to guide preoperative diagnosis. Due to differences in tumor location and size, differential diagnoses made in one article could not be directly applied to other cases. Capillary hemangioma was diagnosed by pathological observations in all cases. However, ICH was not considered in preoperative differential diagnoses. In the present case, a tentorium-based lesion mimicking a meningioma was identified, which was preoperatively diagnosed as an atypical meningioma. Astrocytoma was also considered, with no expectation of the final result. Therefore, preoperatively diagnosing ICHs is difficult.

Treatment for ICH is empirical (22). Different modalities, including surgery, stereotactic radiotherapy, or treatment with corticosteroids or interferon have been used; however, the rationale and indications for different treatments have not been clearly stated in the literature. The vast majority of patients (28 of 29) underwent surgery, among which there were 24 resections and 4 biopsies. A capacity for rapid growth of the lesion was reported and the turmor recurred after a short time in three cases (2,7,18). In symptomatic cases, performing surgery is a less controversial option, however performing surgery in asymptomatic cases should be considered more carefully. Theoretically, conservative observations should be conducted on a regular basis. Taking the final histopathological results into account, it may have been more appropriate for the current patient to undergo conservative observation; however, a tumor that is suspected to be serious requires a more radical approach, such as surgery. In the current case report, the patient refused conservative observation and requested radical surgery as soon as possible. The outcomes of the 29 patients included in the literature review were generally satisfactory, with only one case of mortality and 3 definite recurrences and no more severe neurological defects. More details are shown in Table I.

In conclusion, the present study reported a nearly asymptomatic case of ICH. ICHs are rare entities defined by highly consistent histopathological results but exhibit variable clinical features. The clinical symptoms of ICH are diverse and largely depend on tumor location and size and preoperative diagnosis are difficult to make. Treatment for ICH remains empirical but surgery is the most common method and patients undergoing surgery generally have good prognoses. Although rapid growth and recurrence or massive bleeding during surgery have been reported, the majority of patients achieve long-term survival with no further symptomatic events and no tumor recurrence.

References

  • 1.Daenekindt T, Weyns F, Kho KH, Peuskens D, Engelborghs K, Wuyts J. Giant intracranial capillary hemangioma associated with enlarged head circumference in a newborn. J Neurosurg Pediatr. 2008;1:488–492. doi: 10.3171/PED/2008/1/6/488. [DOI] [PubMed] [Google Scholar]
  • 2.Simon SL, Moonis G, Judkins AR, Scobie J, Burnett MG, Riina HA, Judy KD. Intracranial capillary hemangioma: Case report and review of the literature. Surg Neurol. 2005;64:154–159. doi: 10.1016/j.surneu.2004.10.025. [DOI] [PubMed] [Google Scholar]
  • 3.Uyama A, Kawamura A, Akiyama H, Nakamizo S, Yamamoto K, Nagashima T, Uetani T, Takeda H, Yoshida M. A case of cerebellar capillary hemangioma with multiple cysts. Pediatr Neurosurg. 2008;44:344–349. doi: 10.1159/000138375. [DOI] [PubMed] [Google Scholar]
  • 4.Abe M, Tabuchi K, Tanaka S, Hodozuka A, Kunishio K, Kubo N, Nishimura Y. Capillary hemangioma of the central nervous system. J Neurosurg. 2004;101:73–81. doi: 10.3171/jns.2004.101.1.0073. [DOI] [PubMed] [Google Scholar]
  • 5.Pignotti F, Coli A, Fernandez E, Montano N. Capillary hemangioma of the cauda equina. Surg Neurol Int. 2015;6:133. doi: 10.4103/2152-7806.162551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Roncaroli F, Scheithauer BW, Krauss WE. Hemangioma of spinal nerve root. J Neurosurg. 1999;91:S175–S180. doi: 10.3171/spi.1999.91.2.0175. (2 Suppl) [DOI] [PubMed] [Google Scholar]
  • 7.Phi JH, Kim SK, Cho A, Kim DG, Paek SH, Park SH, Wang KC. Intracranial capillary hemangioma: Extra-axial tumorous lesions closely mimicking meningioma. J Neurooncol. 2012;109:177–185. doi: 10.1007/s11060-012-0884-6. [DOI] [PubMed] [Google Scholar]
  • 8.Karikari IO, Selznick LA, Cummings TJ, George TM. Capillary hemangioma of the fourth ventricle in an infant. Case report and review of the literature. J Neurosurg. 2006;104:S188–S191. doi: 10.3171/ped.2006.104.3.188. (3 Suppl) [DOI] [PubMed] [Google Scholar]
  • 9.Willing SJ, Faye-Petersen O, Aronin P, Faith S. Radiologic-pathologic correlation. Capillary hemangioma of the meninges. AJNR Am J Neuroradiol. 1993;14:529–536. [PMC free article] [PubMed] [Google Scholar]
  • 10.Jalloh I, Dean AF, O'Donovan DG, Cross J, Garnett MR, Santarius T. Giant intracranial hemangioma in a neonate. Acta Neurochir (Wien) 2014;156:1151–1154. doi: 10.1007/s00701-014-2007-y. [DOI] [PubMed] [Google Scholar]
  • 11.Shah ZK, Peh WC, Shek TW, Wong JW, Chien EP. Hemangioendothelioma with an epithelioid phenotype arising in hemangioma of the fibula. Skeletal Radiol. 2005;34:750–754. doi: 10.1007/s00256-005-0912-0. [DOI] [PubMed] [Google Scholar]
  • 12.Frei-Jones M, McKinstry RC, Perry A, Leonard JR, Park TS, Rubin JB. Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma. J Neurosurg Pediatr. 2008;2:125–129. doi: 10.3171/PED/2008/2/8/125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Suss RA, Kumar AJ, Dorfman HD, Miller NR, Rosenbaum AE. Capillary hemangioma of the sphenoid bone. Skeletal Radiol. 1984;11:102–107. doi: 10.1007/BF00348797. [DOI] [PubMed] [Google Scholar]
  • 14.Yang G, Li C, Chen X, Liu Y, Han D, Gao X, Kawamoto K, Zhao S. Large capillary hemangioma of the temporal bone with a dural tail sign: A case report. Oncol Lett. 2014;8:183–186. doi: 10.3892/ol.2014.2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tsao MN, Schwartz ML, Bernstein M, Halliday WC, Lightstone AW, Hamilton MG, Jaywant S, Laperriere N. Capillary hemangioma of the cavernous sinus. Report of two cases. J Neurosurg. 2003;98:169–174. doi: 10.3171/jns.2003.98.1.0169. [DOI] [PubMed] [Google Scholar]
  • 16.Brotchi J, Baleriaux D, Kalangu KK, Morelli D, Rodesch G, Rorive S, Pirotte B. Capillary hemangioma in the superior sagittal sinus as a rare cause of intracranial hypertension in a child: Case report. Neurosurgery. 2005;57:E815. doi: 10.1093/neurosurgery/57.4.E815. [DOI] [PubMed] [Google Scholar]
  • 17.Le Bihannic A, Michot C, Heckly A, Loget P, Beucher A, Brassier G, Hamlat A. Capillary haemangioma arising from the anterior choroidal artery. Childs Nerv Syst. 2005;21:265–271. doi: 10.1007/s00381-004-1085-1. [DOI] [PubMed] [Google Scholar]
  • 18.Morace R, Marongiu A, Vangelista T, Galasso V, Colonnese C, Giangaspero F, Innocenzi G, Esposito V, Cantore G. Intracranial capillary hemangioma: A description of four cases. World Neurosurg. 2012;78(191):E15–E21. doi: 10.1016/j.wneu.2011.09.017. [DOI] [PubMed] [Google Scholar]
  • 19.Maurer GD, Schittenhelm J, Ernemann U, Kempf VA, Ritz R, Weller M, Schmidt F. Intracranial hemangiomas in a patient with POEMS syndrome. J Neurol. 2010;257:484–487. doi: 10.1007/s00415-009-5398-6. [DOI] [PubMed] [Google Scholar]
  • 20.Younas F, Durrani Q, Shahzad MA, Mushtaq A, Imlay S. Multiple intracranial capillary hemangiomas and transient cerebrovascular insufficiency. Neurol Sci. 2011;32:963–966. doi: 10.1007/s10072-011-0569-5. [DOI] [PubMed] [Google Scholar]
  • 21.Smith IF, Skelton V. An unusual intracranial tumour presenting in pregnancy. Int J Obstet Anesth. 2007;16:82–85. doi: 10.1016/j.ijoa.2006.04.016. [DOI] [PubMed] [Google Scholar]
  • 22.Mirza B, Shi WY, Phadke R, Holton JL, Turner C, Plant GT, Brew S, Kitchen N, Zrinzo L. Strawberries on the brain-intracranial capillary hemangioma: Two case reports and systematic literature review in children and adults. World Neurosurg. 2013;80(900):e13–e21. doi: 10.1016/j.wneu.2012.12.013. [DOI] [PubMed] [Google Scholar]
  • 23.Lee YH, Park YS, Kim DS, Park YG, Shim KW. 59-year old female with suprasellar mass. Brain Pathol. 2010;20:257–260. doi: 10.1111/j.1750-3639.2009.00345.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.John SG, Pillai U, Lacasse A. Intracranial capillary hemangioma mimicking a dissociative disorder. Clin Pract. 2012;2:e35. doi: 10.4081/cp.2012.e35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zheng SP, Ju Y, You C. Giant intracranial capillary hemangioma in a 3-year-old child: Case report and literature review. Clin Neurol Neurosurg. 2012;114:1270–1273. doi: 10.1016/j.clineuro.2012.02.052. [DOI] [PubMed] [Google Scholar]

Articles from Experimental and Therapeutic Medicine are provided here courtesy of Spandidos Publications

RESOURCES